Clinical Trial Update: A Study to Learn About the Amount of the Study Medicine (Sisunatovir) in Blood and Its Safety in Infants and Children With Pneumonia Caused by RSV [Phase 1]

View source ↗

Summary

Phase 1 study of Sisunatovir in infants and children with pneumonia due to respiratory syncytial virus was terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumonia
• Respiratory Syncytial Virus Infection

Drugs mentioned

• Sisunatovir (Sisunatovir)

Snippet

Sponsor: Pfizer | Conditions: Respiratory Syncytial Virus Infections | Phase 1 | Status: TERMINATED | Results posted: 2025-12-30